Neoleukin Therapeutics

NGNE

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-83.53M

EBITDA$-71.14M

EBIT$-75.13M

Pre-tax Income$-87.22M

Net Income$-75.14M

Cash Equivalent$116.44M

Total Debt$13.76M

Book Value$193.4M

Book Value Per Share14.41

Return on Equity (ROE)-24.21%

Return on Assets (ROA)-22.38%

Return on Invested Capital (ROI)-24.20%

Net Profit Margin-8123.68%

Current Ratio20.84

Quick Ratio20.72

Long-Term Debt / Equity0.25